Epstein	O
-	O
Barr	O
virus	O
-	O
associated	O
nonsmall	B-Cancer
cell	I-Cancer
lung	I-Cancer
carcinoma	I-Cancer
:	O
undifferentiated	O
"	B-Cancer
lymphoepithelioma	I-Cancer
-	I-Cancer
like	I-Cancer
"	I-Cancer
carcinoma	I-Cancer
as	O
a	O
distinct	O
entity	O
with	O
better	O
prognosis	O
.	O

BACKGROUND	O
:	O

Epstein	O
-	O
Barr	O
virus	O
(	O
EBV	O
)	O
infection	O
in	O
nonsmall	B-Cancer
cell	I-Cancer
lung	I-Cancer
carcinoma	I-Cancer
(	O
NSCLC	B-Cancer
)	O
has	O
been	O
demonstrated	O
in	O
some	O
ethnic	O
groups	O
.	O

The	O
pathobiology	O
and	O
the	O
role	O
of	O
EBV	O
and	O
oncoprotein	O
expression	O
in	O
these	O
tumors	B-Cancer
have	O
not	O
been	O
studied	O
extensively	O
.	O

In	O
this	O
study	O
,	O
the	O
authors	O
investigated	O
EBV	O
-	O
encoded	O
RNA	O
-	O
1	O
(	O
EBER1	O
)	O
transcripts	O
by	O
in	O
situ	O
hybridization	O
and	O
the	O
expression	O
of	O
latent	O
membrane	O
protein	O
-	O
1	O
(	O
LMP	O
-	O
1	O
)	O
and	O
bcl	O
-	O
2	O
protein	O
by	O
immunohistochemistry	O
in	O
NSCLC	B-Cancer
patients	O
from	O
Taiwan	O
,	O
where	O
nasopharyngeal	B-Cancer
carcinoma	I-Cancer
is	O
endemic	O
.	O

METHODS	O
:	O

A	O
total	O
of	O
127	O
cases	O
of	O
NSCLC	B-Cancer
(	O
43	O
cases	O
of	O
squamous	B-Cancer
cell	I-Cancer
carcinoma	I-Cancer
[	O
SCC	B-Cancer
]	O
,	O
67	O
cases	O
of	O
adenocarcinoma	B-Cancer
[	O
AD	B-Cancer
]	O
,	O
12	O
cases	O
of	O
large	B-Cancer
cell	I-Cancer
carcinoma	I-Cancer
[	O
LCC	B-Cancer
]	O
,	O
and	O
5	O
cases	O
of	O
lymphoepithelioma	B-Cancer
-	I-Cancer
like	I-Cancer
carcinoma	I-Cancer
[	O
LE	B-Cancer
]	O
)	O
were	O
included	O
.	O

A	O
sensitive	O
polymerase	O
chain	O
reaction	O
-	O
derived	O
,	O
digoxigenin	O
-	O
labeled	O
DNA	O
probe	O
for	O
in	O
situ	O
detection	O
of	O
EBER1	O
transcripts	O
was	O
performed	O
for	O
the	O
detection	O
of	O
EBV	O
.	O

Immunohistochemistry	O
using	O
the	O
avidin	O
-	O
biotin	O
-	O
immunoperoxidase	O
method	O
was	O
also	O
performed	O
to	O
evaluate	O
the	O
expression	O
of	O
bcl	O
-	O
2	O
and	O
LMP	O
-	O
1	O
.	O

RESULTS	O
:	O

EBER1	O
was	O
detected	O
in	O
11	O
of	O
the	O
127	O
NSCLC	B-Cancer
cases	O
(	O
8	O
.	O
7	O
%	O
;	O
6	O
SCC	B-Cancer
cases	O
and	O
5	O
LE	B-Cancer
cases	O
)	O
.	O

All	O
5	O
LE	B-Cancer
cases	O
were	O
EBV	O
-	O
positive	O
,	O
whereas	O
only	O
6	O
of	O
the	O
43	O
SCC	B-Cancer
cases	O
(	O
14	O
%	O
)	O
,	O
0	O
of	O
67	O
AD	B-Cancer
cases	O
,	O
and	O
12	O
LCC	B-Cancer
cases	O
were	O
EBV	O
-	O
positive	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

All	O
five	O
LE	B-Cancer
cases	O
showed	O
diffuse	O
,	O
strong	O
,	O
positive	O
staining	O
of	O
tumor	B-Cell
cells	I-Cell
;	O
five	O
of	O
the	O
six	O
SCC	B-Cancer
cases	O
showed	O
diffuse	O
but	O
weak	O
staining	O
.	O

Among	O
the	O
nontumor	B-Cell
epithelial	I-Cell
cells	I-Cell
,	O
there	O
was	O
no	O
EBER1	O
staining	O
of	O
any	O
of	O
the	O
11	O
EBER1	O
-	O
positive	O
cases	O
.	O

The	O
mean	O
age	O
of	O
the	O
LE	B-Cancer
patients	O
was	O
10	O
years	O
younger	O
than	O
that	O
of	O
the	O
patients	O
with	O
other	O
histological	O
types	O
.	O

All	O
5	O
LE	B-Cancer
patients	O
were	O
nonsmokers	O
,	O
whereas	O
3	O
of	O
the	O
6	O
patients	O
with	O
EBER1	O
-	O
positive	O
SCC	B-Cancer
(	O
50	O
%	O
)	O
were	O
smokers	O
.	O

EBER1	O
expression	O
did	O
not	O
correlate	O
with	O
the	O
2	O
-	O
year	O
survival	O
rate	O
of	O
overall	O
cases	O
,	O
but	O
all	O
5	O
LE	B-Cancer
patients	O
were	O
alive	O
without	O
clinical	O
evidence	O
of	O
disease	O
at	O
last	O
follow	O
-	O
up	O
.	O

Gender	O
,	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
or	O
distant	O
metastasis	O
,	O
and	O
clinical	O
stage	O
were	O
not	O
found	O
to	O
have	O
any	O
correlation	O
with	O
EBER1	O
expression	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

All	O
LE	B-Cancer
cases	O
had	O
bcl	O
-	O
2	O
oncoprotein	O
expression	O
(	O
100	O
%	O
)	O
.	O

This	O
frequency	O
was	O
significantly	O
different	O
from	O
other	O
histologic	O
types	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
LMP	O
-	O
1	O
detection	O
rate	O
was	O
low	O
and	O
demonstrated	O
no	O
correlation	O
with	O
bcl	O
-	O
2	O
expression	O
.	O

CONCLUSIONS	O
:	O

In	O
this	O
study	O
,	O
the	O
authors	O
found	O
that	O
the	O
primary	B-Cancer
LE	I-Cancer
of	O
the	O
lung	B-Organ
is	O
associated	O
with	O
young	O
age	O
,	O
a	O
history	O
of	O
not	O
smoking	O
,	O
high	O
bcl	O
-	O
2	O
immunoreactivity	O
,	O
and	O
better	O
survival	O
rate	O
.	O

These	O
characteristics	O
demonstrate	O
that	O
EBV	O
-	O
associated	O
LE	B-Cancer
of	O
the	O
lung	B-Organ
is	O
a	O
unique	O
entity	O
.	O

The	O
findings	O
of	O
the	O
current	O
study	O
suggest	O
that	O
EBV	O
infection	O
may	O
play	O
a	O
different	O
role	O
in	O
the	O
tumorigenesis	O
of	O
primary	B-Cancer
LE	I-Cancer
of	O
the	O
lung	B-Organ
than	O
it	O
does	O
in	O
other	O
EBER1	B-Cancer
-	I-Cancer
positive	I-Cancer
NSCLCs	I-Cancer
.	O

